Sequential capecitabine-based treatment of patients with metastatic colorectal cancer (MCRC) combined with oxaliplatin first-line: A retrospective analysis

3631 Background: A favorable outcome of first-line therapy of capecitabine (XEL) and oxaliplatin (XELOX) was recently documented for patients with MCRC. Retrospectively, we analyzed MCRC patients t...